ENVX earnings analysis
What we found in ENVX's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Enovix’s Q2 2026 revenue increased to $9.024 million, rising both sequentially and year over year, while GAAP EPS of $(0.20) improved year over year but remained deeply negative. Liquidity was $552.1 million, but the company continues to report substantial losses, an accumulated deficit of approximately $1.06 billion, and significant convertible debt. The investment case remains balanced between improving revenue momentum and the substantial risks associated with customer concentration, manufacturing scale-up, YBS dependence, and continued cash requirements.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue rebounded sequentially and year over year
- Revenue was $9.024 million, up approximately 12.8% from $8 million in Q1 2026 and approximately 28.9% from $7 million in Q2 2025.
- EPS improved year over year
- GAAP EPS was $(0.20), improving from $(0.22) in Q2 2025 but worsening from $(0.18) in Q1 2026.
- Quarterly net loss narrowed year over year
- Net loss attributable to Enovix was approximately $43.1 million, modestly better than the $44.5 million loss in the year-earlier quarter.
- Liquidity reserve remains substantial
- Cash, cash equivalents, restricted cash, and short- and long-term investments totaled $552.1 million as of July 5, 2026, providing a substantial liquidity reserve relative to current revenue.
- No reported control deficiencies
- Management stated that disclosure controls and procedures were effective at a reasonable assurance level as of July 5, 2026, and reported no changes in internal control that materially affected the quarter.
- Fab2 lease extended into 2027
- The Fab2 lease was renewed for one year in April 2026, extending its expiration to July 31, 2027 and supporting near-term manufacturing continuity.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Dependence on YBS manufacturing partner
- The filing identifies reliance on the YBS manufacturing agreement as a changed risk. The agreement runs for 10 years through July 2033, includes a minimum purchase commitment, and YBS provides facility, staffing, and procurement support.
- Persistent losses and commercialization risk
- The company reported $43.1 million of net loss for the quarter and an accumulated deficit of approximately $1.06 billion as of July 5, 2026, while stating that losses are expected to continue until significant production begins.
- Substantial convertible debt burden
- Debt included $172.5 million of 3.00% 2028 Convertible Senior Notes and $360.0 million of 4.75% 2030 Convertible Senior Notes, or approximately 98% of total debt before issuance costs.
- Material customer concentration
- One South Korean defense subcontractor accounted for the majority of total revenue in the quarter ended July 5, 2026, creating significant exposure to customer retention, contract changes, and demand reductions.
- Manufacturing scale-up remains unproven
- The company states that its manufacturing process is not currently operating at scale and that improving throughput and yield is expected to be a multi-quarter or potentially longer endeavor.
- Near-term facility continuity risk
- Fab2’s current lease expires on July 31, 2027; failure to secure another extension or implement an alternative facility could disrupt operations at the company’s principal manufacturing site.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.2
What they said about what is next.
The 10-Q does not provide explicit numeric revenue or EPS guidance. Q3 2026 outlook was provided in the earnings release: revenue of $9.0 million-$10.0 million, non-GAAP EPS of $(0.13)-$(0.17), and capital expenditures of $8.0 million-$12.0 million; no prior outlook was disclosed for comparison.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 13, 2026
- Enovix Corporation reported robust Q1 2026 results with revenues of $7.6 million, a 49% increase year-over-year, and an EPS loss of -$0.14, exceeding expectations. Management is optimistic about ongoing growth in the…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing ENVX makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever